echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical World News > Hospitals have been posted a report letter that drug companies have been suspended

    Hospitals have been posted a report letter that drug companies have been suspended

    • Last Update: 2020-11-15
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Recently, it was revealed that a number of sanjia hospitals in a certain place have been posted anonymous report letters, all related to drug rebates.
    The report letter refers directly to the abnormal sales relationship between doctors and medical representatives in some departments of the hospital, from which gold is sold, and the whistleblower said that the relevant situation has been sent to the provincial inspection team, the municipal discipline inspection committee, the hospital leadership office and other relevant units.
    , according to industry sources, in response to the relevant reports, hospital procurement staff are being investigated, there are pharmaceutical companies have been suspended.
    while reporting may only be an act of competition between drug companies and competitors, it has to be mentioned that a strict investigation into drug rebates and a crack on medical corruption is indeed the weathers for the relevant departments this year.
    , the National Health and Health Commission announced that the 22nd meeting of the Inter-ministerial Joint Meeting on Correcting The Wrong Winds in the Field of Pharmaceutical Purchase and Sale and Medical Services was held in Beijing.
    meeting called for the consolidation of the effectiveness of the pharmaceutical circulation in 2020, resolutely clean up the industry chaos, actively respond to the risk of epidemic prevention and control, a new round of anti-wind work, continue.
    we can also see that in recent months, state regulators have frequently issued anti-corruption documents on the field of pharmaceutical purchases and sales.
    On June 5, the National Health and Health Commission, the Ministry of Industry and Information Technology, the Ministry of Public Security and other nine departments jointly issued the "2020 correction of the field of pharmaceutical purchase and sale and medical services in the field of the wrong wind work points", clearly for the pharmaceutical purchase and sale of the field and medical services to draw a clear red line of behavior, the formation of a clean air of the industry.
    including serious investigation and prosecution of the collection of pharmaceutical supplies enterprise rebate behavior.
    July 23, the General Office of the State Council issued the Key Tasks for Deepening the Reform of the Medical and Health System in the Second Half of 2020, which mentions the need to improve the mechanism of comprehensive supervision and supervision of the medical and health industry, and to carry out the pilot work of "Credit plus Comprehensive Supervision".
    July 24, the General Office of the National Health and Safety Commission issued a Notice on the Issue of a Special Action Plan for the Construction of The Style of the Medical Industry in 2020, which mentioned that it would crack down on the illegality of collecting kickbacks from medical institutions.
    August 4, the Central Commission for Discipline Inspection, the National Supervision Commission website published the "focus areas of positive wind anti-corruption observation, dig deep to investigate medical corruption" article, which mentioned that since this year, discipline inspection and supervision organs at all levels earnestly implement the 19th Central Commission for Discipline Inspection four plenary sessions of the work deployment, based on functional responsibilities, adhere to the sub-sector in-depth investigation, in-depth rectification of corruption and style issues in the medical field, cut off the health care sector corruption interest chain, and constantly reduce the gray space
    August 16, the website of the State Supervision Commission of the Central Commission for Discipline Inspection published an article on "Precise consultation and removal of corruption lesions in the medical field by the Tibet Discipline Inspection and Supervision Organ", pointing out that the joint research group of the Commission for Discipline Inspection of the Tibet Autonomous Region found that "corruption in the medical field is relatively concentrated, mainly in the areas of pharmaceutical purchase and sale, hospital infrastructure, and the management and use of medical insurance funds".
    September 2, the website of the State Supervision Commission of the Central Commission for Discipline Inspection published "To take the case as a guide, Chengdu seriously rectify the problem of corruption in the medical field", the article pointed out that some medical institutions unreasonable drug use, unreasonable inspection and inspection, unreasonable use of high-value medical supplies and other phenomena occur from time to time.
    , the president of the three majors, the director of the pharmacy department has fallen since this year, anti-corruption high-pressure has been sustained.
    , the Sichuan Provincial Commission for Discipline Inspection issued a message that Gu Yunxuan, director of the People's Hospital of Aba County, Sichuan Province, is under disciplinary review and supervision investigation for suspected serious disciplinary violations.
    the official information of the hospital, Sebastlu, found that not only the dean, since August 29, the hospital's chief of general services, the director of the pharmacy department has also been dropped.
    It is understood that the Aba State Commission for Discipline Inspection has previously announced that from May 2020 will be carried out in the state-wide six-month system of governance, which in the field of health care, focusing on the management of illegal purchase of medical equipment, prescriptions, excessive use of consumables and drugs, take "commission", eat "kickbacks", receive "red envelopes", through internal and external collusion fraud fraud and other issues.
    the fall of the above-mentioned medical personnel should be the result of the corrective action.
    with the National Health and Safety Commission issued "on the issuance of 2020 medical industry style construction work special action plan notice", hospital rectification has been widely concerned, all over the public hospital inspection and implementation program.
    understood that the vast majority of hospitals are currently on high alert, medical representatives have once again become the focus of public opinion.
    recent times, the industry from time to time out of the hospital to inform medical representatives not to go to the hospital, medical representatives were taken away, and even about the drug was suspended news.
    With the advance of national procurement, the development of tax verification in the pharmaceutical industry, as well as the two-vote system, health insurance fee control policy, coupled with a strict investigation of drug rebates, crack down on medical corruption, the past rely on high drug pricing, channel space to pull sales of traditional drug marketing methods will be completely subverted, pharmaceutical companies must be timely transformation.
    and the medical representative, it is time for an urgent transformation.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.